Population Analytics
What the Armamentarium looks like in aggregate — the shape of everything PANOPTICON makes and holds, by type, BCL grade, disclosure class, approval status, and channel. Drawn live from the registry.
Assets by Type
By BCL Containment Grade
By Approval Status
By Channel
Methodology & Data Quality
How These Figures Are Produced
All analytics on this page are computed by PANACEA from the live Armamentarium registry — the canonical ledger of every compound, implant, device, biological, and vector under Directorate control. Asset records are ingested from the registry's write-ahead log as they change; charts refresh on each page load. Counts reflect current-state snapshots, not historical aggregates; for trend analysis, consult the Control Metrics time-series dashboards.
Known Limitations
Black-Label assets under Director seal are included in aggregate counts but suppressed from drill-down breakdowns — total counts may therefore exceed the sum of visible category slices. BCL-4 vault holdings are updated on a 24-hour cycle, not in real time, due to air-gapped containment protocols. Approval-status labels reflect the most permissive jurisdiction; an asset marked "FDA-Approved" may carry a different classification in EMA or PMDA territories.
Reading the Charts
The primary classification of each Armamentarium entry — drugs, implants, vaccines, devices, biologicals, gene-therapy vectors, and classified agents. The distribution reflects PANOPTICON's pharmaceutical-first doctrine: the majority of assets are small-molecule drugs because mass oral dosing remains the cheapest route to population coverage.
Biocontainment Level distribution. BCL-1 and BCL-2 assets form the public-facing catalogue; BCL-3 assets are restricted-access investigational lines; BCL-4 entries are vault-only holdings — gain-of-function strains, classified biological agents, and contingency stockpile material that exists under Director seal.